

LONDON, July 14 (Reuters) - ViiV Healthcare, the HIV-focused joint venture majority owned by GSK, said on Monday it has expanded its licensing deal ...


(Alliance News) - GSK PLC on Monday said it has submitted a US regulatory application for the expanded use of its Arexvy respiratory syncytial virus v...


(Alliance News) - DCC announced a deal to sell a part of its technology arm for GBP100 million, GSK is pursuing US approval for expanded use of its RS...


(Sharecast News) - GSK said the US Food and Drug Administration has accepted an application for review to extend the indication of its Arexvy respirat...


(Alliance News) - London's FTSE 100 closed a winning week on the back foot after soft economic growth figures and threats of further tariffs from the ...


(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:


Patients allege that heartburn drug caused their cancer *


July 10 (Reuters) - Delaware's highest court ruled on Thursday that patients suing drugmakers GSK, Pfizer , Sanofi and Boehringer Ingelheim cannot ...